Canada Pension Plan Investment Board Has $60.80 Million Stake in Waters Corporation $WAT

Canada Pension Plan Investment Board raised its position in Waters Corporation (NYSE:WAT - Free Report) by 2,711.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 162,120 shares of the medical instruments supplier's stock after acquiring an additional 156,353 shares during the quarter. Canada Pension Plan Investment Board owned approximately 0.17% of Waters worth $60,801,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Zions Bancorporation National Association UT raised its holdings in shares of Waters by 121.2% in the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 40 shares during the period. SHP Wealth Management bought a new position in Waters during the fourth quarter worth about $32,000. DV Equities LLC bought a new position in Waters during the fourth quarter worth about $32,000. Anchor Investment Management LLC acquired a new position in Waters during the first quarter worth approximately $27,000. Finally, Resources Management Corp CT ADV acquired a new position in Waters during the first quarter worth approximately $27,000. Institutional investors own 94.01% of the company's stock.

Waters Stock Up 1.5%

WAT stock opened at $420.35 on Friday. Waters Corporation has a fifty-two week low of $282.77 and a fifty-two week high of $426.22. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.86 and a quick ratio of 1.29. The stock has a market capitalization of $41.30 billion, a price-to-earnings ratio of 104.82, a PEG ratio of 2.41 and a beta of 1.19. The business's fifty day moving average price is $386.36 and its two-hundred day moving average price is $347.99.

Waters (NYSE:WAT - Get Free Report) last announced its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.01 by $0.04. Waters had a net margin of 3.58% and a return on equity of 11.27%. The company had revenue of $1.65 billion during the quarter, compared to analysts' expectations of $1.62 billion. During the same quarter in the previous year, the business posted $2.95 earnings per share. Waters's quarterly revenue was up 113.3% on a year-over-year basis. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. On average, equities analysts anticipate that Waters Corporation will post 14.56 earnings per share for the current year.

Insider Transactions at Waters

In other Waters news, Director Christopher A. Kuebler sold 3,626 shares of the business's stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the sale, the director owned 17,808 shares of the company's stock, valued at $7,086,515.52. The trade was a 16.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.31% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have recently issued reports on WAT. Barclays raised their price objective on Waters from $425.00 to $460.00 and gave the company an "overweight" rating in a research report on Wednesday, August 5th. Piper Sandler raised Waters from a "neutral" rating to an "overweight" rating and boosted their target price for the stock from $400.00 to $480.00 in a report on Thursday. Weiss Ratings cut Waters from a "hold (c)" rating to a "hold (c-)" rating in a research note on Wednesday, August 12th. Robert W. Baird set a $387.00 price target on Waters in a report on Wednesday, May 6th. Finally, Bank of America lifted their price objective on shares of Waters from $370.00 to $400.00 and gave the stock a "neutral" rating in a research report on Tuesday, June 2nd. Three analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, Waters presently has an average rating of "Moderate Buy" and an average target price of $424.35.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source